| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.27 | 0.1 |